Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000518163 | SCV000612584 | benign | not specified | 2017-06-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000550382 | SCV000632195 | benign | Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002285348 | SCV002575465 | likely benign | not provided | 2021-05-05 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Breakthrough Genomics, |
RCV002285348 | SCV005296392 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004535668 | SCV004731098 | benign | CACNA1H-related disorder | 2019-04-12 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |